Medprin Regenerative Medical Technologies Co. Ltd. engages in the development of implanted medical devices. Its product specializes in using advanced manufacturing technology in combination with the characteristics of artificial synthetic materials. The firm's neurosurgery implanted medical device products include artificial dural (spine) membrane patch, cranio-maxillofacial repair products, and absorbable hemostatic gauze. The company was founded on September 2, 2008 and is headquartered in Guangzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company